These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evaluation of families wherein a single male manifests a phenotype of X-linked lymphoproliferative disease (XLP). Grierson HL; Skare J; Church J; Silberman T; Davis JR; Kobrinsky N; McGregor R; Israels S; McCarty J; Andrews LG Am J Med Genet; 1993 Sep; 47(4):458-63. PubMed ID: 8256804 [TBL] [Abstract][Full Text] [Related]
8. Cytogenetic studies of Burkitt lymphoma-leukemia in patients with acquired immunodeficiency syndrome. Bernheim A; Berger R Cancer Genet Cytogenet; 1988 May; 32(1):67-74. PubMed ID: 3162708 [TBL] [Abstract][Full Text] [Related]
9. [Genetic and proteinic analysis of a Chinese boy with X-linked lymphoproliferative disease and his maternal relatives]. Yang X; Wang J; An YF; Kanegane H; Miyawaki T; Zhao XD Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):416-20. PubMed ID: 21924052 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-associated lymphoproliferative syndromes: studies in two European families. Schuster V; Dohrmann E; Kreth HW Cancer Detect Prev; 1991; 15(1):65-7. PubMed ID: 1646073 [TBL] [Abstract][Full Text] [Related]
13. Deficiency of the proapoptotic SAP function in X-linked lymphoproliferative disease aggravates Epstein-Barr virus (EBV) induced mononucleosis and promotes lymphoma development. Nagy N; Klein E Immunol Lett; 2010 May; 130(1-2):13-8. PubMed ID: 20080127 [TBL] [Abstract][Full Text] [Related]
14. Report on the X-linked lymphoproliferative disease in an Australian family. Turner AM; Berdoukas VA; Tobias VH; Ziegler JB; Toogood IR; Mulley JC; Skare J; Purtilo DT J Paediatr Child Health; 1992 Apr; 28(2):184-9. PubMed ID: 1562373 [TBL] [Abstract][Full Text] [Related]
15. Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: Report of five cases with three novel mutations and review of the literature. Jin YY; Zhou W; Tian ZQ; Chen TX Hum Immunol; 2016 Aug; 77(8):658-666. PubMed ID: 27288720 [TBL] [Abstract][Full Text] [Related]
16. Immunodeficiency as a factor in lymphomagenesis. Purtilo DT; Sakamoto K Perspect Pediatr Pathol; 1984; 8(2):181-91. PubMed ID: 6330665 [TBL] [Abstract][Full Text] [Related]
17. Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome. Purtilo DT; DeFlorio D; Hutt LM; Bhawan J; Yang JP; Otto R; Edwards W N Engl J Med; 1977 Nov; 297(20):1077-80. PubMed ID: 198660 [TBL] [Abstract][Full Text] [Related]
18. Cytogenetic studies on patients of acute lymphoblastic leukemia Burkitt's type with (8;14) & (14;18) translocations. Gladstone B; Kadam PR; Balsara BR; Pai SK; Gopal R; Nair CN; Parikh PM; Saikia T; Advani SH Indian J Med Res; 1994 Jun; 99():264-6. PubMed ID: 8088887 [TBL] [Abstract][Full Text] [Related]
19. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients. Purtilo DT AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295 [TBL] [Abstract][Full Text] [Related]
20. Persistent hypogammaglobulinemia following mononucleosis in boys is highly suggestive of X-linked lymphoproliferative disease--report of three cases. Hügle B; Suchowerskyj P; Hellebrand H; Adler B; Borte M; Sack U; Overberg-Schmidt US; Strnad N; Otto J; Meindl A; Schuster V J Clin Immunol; 2004 Sep; 24(5):515-22. PubMed ID: 15359110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]